These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combined modalities of surgery, radiotherapy, radiosurgery and chemotherapy for invasive pituitary carcinoma. Tuleasca C; Messerer M; Levivier M; Daniel RT Ann Endocrinol (Paris); 2018 Apr; 79(2):82-85. PubMed ID: 29525560 [No Abstract] [Full Text] [Related]
3. Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas. Zhang D; Way JS; Zhang X; Sergey M; Bergsneider M; Wang MB; Yong WH; Heaney AP J Clin Endocrinol Metab; 2019 Jun; 104(6):1929-1936. PubMed ID: 30624667 [TBL] [Abstract][Full Text] [Related]
4. Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment. Yano S; Hide T; Uekawa K; Honda Y; Mikami Y; Kuratsu JI World Neurosurg; 2016 Nov; 95():620.e17-620.e22. PubMed ID: 27535625 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma. Meyer P; Bohnen NI; Barkan AL; Shapiro B Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234 [TBL] [Abstract][Full Text] [Related]
7. Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors. Raverot G; Vasiljevic A; Jouanneau E; Lasolle H Eur J Endocrinol; 2019 Aug; 181(2):C1-C3. PubMed ID: 31167164 [TBL] [Abstract][Full Text] [Related]
8. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma? Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771 [TBL] [Abstract][Full Text] [Related]
16. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report. Koguchi M; Nakahara Y; Ebashi R; Ogata A; Shimokawa S; Masuoka J; Abe T J Med Case Rep; 2019 Jan; 13(1):18. PubMed ID: 30660191 [TBL] [Abstract][Full Text] [Related]
17. Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review. Dai C; Sun B; Guan S; Wang W; Liu H; Li Y; Zhang J; Kang J BMC Endocr Disord; 2021 Oct; 21(1):217. PubMed ID: 34715828 [TBL] [Abstract][Full Text] [Related]